Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
Eo
Wan Kyu
WK
Kim
Se Hyun
SH
Cheon
Seong Ha
SH
Lee
Sang Hun
SH
Jeong
Jong Soo
JS
Kim
Yang Soo
YS
Chang
Hee Kyung
HK
Suh
Kee Suck
KS
Kim
Heung Yeol
HY
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous; D013792:Thalidomide; D003907:Dexamethasone